Literature DB >> 26932594

Hypertension and non-alcoholic fatty liver disease proven by transient elastography.

Yaohui Wang1, Yuhua Zeng1, Changwei Lin2, Zhiheng Chen1.   

Abstract

AIM: The relationship between non-alcoholic fatty liver disease (NAFLD) and hypertension is poorly understood. In the present study, we aimed to assess the relationship between essential hypertension and NAFLD, by using a new diagnostic tool, transient elastography (TE).
METHODS: We enrolled 836 subjects in this study. All subjects underwent a comprehensive questionnaire survey and blood test. Each patient had undergone TE to detect the controlled attenuation parameter, which was used to and quantify liver steatosis with the help of TE.
RESULTS: Participants with hypertension showed a higher prevalence of NAFLD defined by TE (P < 0.05). After adjusting for body mass index (BMI), aspartate aminotransferase (AST), alanine aminotransferase, triglycerides, total cholesterol, and high-density lipoprotein cholesterol, the odds ratio for NAFLD, comparing the grade 3 group (systolic blood pressure level ≥ 180 mmHg and/or diastolic blood pressure level ≥ 110 mmHg) with the normal group, was 1.476 (95% confidence interval, 1.166-2.551). A stepwise multivariate linear regression analysis (R2  = 0.084, P = 0.043) retained NAFLD, BMI, and AST as significant predictors of the systolic blood pressure levels. Additionally, stepwise multivariate linear regression analysis (R2  = 0.199, P = 0.037) retained NAFLD, controlled attenuation parameter, BMI, triglycerides, and high-density lipoprotein cholesterol as significant predictors of diastolic blood pressure levels. In addition, BMI, AST, and alanine aminotransferase were associated with systolic blood pressure levels among individuals with NAFLD; BMI, AST, and total cholesterol were associated with diastolic blood pressure levels among individuals with NAFLD.
CONCLUSION: The main finding of our study is that hypertensive patients have a higher prevalence of NAFLD defined by TE, and NAFLD is independently associated with hypertension and blood pressure category.
© 2016 The Japan Society of Hepatology.

Entities:  

Keywords:  controlled attenuation parameter; essential hypertension; hepatic steatosis; non-alcoholic fatty liver disease; transient elastography

Year:  2016        PMID: 26932594     DOI: 10.1111/hepr.12688

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  11 in total

1.  Risk Assessment of Hepatocellular Carcinoma in General Population by Liver Stiffness in Combination with Controlled Attenuation Parameter using Transient Elastography: A Cross Sectional Study.

Authors:  Takaaki Sugihara; Masahiko Koda; Tomomitsu Matono; Kinya Okamoto; Yoshikazu Murawaki; Hajime Isomoto; Shiho Tokunaga
Journal:  Yonago Acta Med       Date:  2017-06-26       Impact factor: 1.641

2.  Quantitative Ultrasound Assessment of Hepatic Steatosis.

Authors:  Artem Kaliaev; Wilson Chavez; Jorge Soto; Fahimul Huda; Hua Xie; Man Nguyen; Vijay Shamdasani; Stephan Anderson
Journal:  J Clin Exp Hepatol       Date:  2022-01-31

3.  Elevated Alanine Aminotransferase in Early Pregnancy and Subsequent Development of Gestational Diabetes and Preeclampsia.

Authors:  Seung Mi Lee; Joong Shin Park; You Jung Han; Won Kim; Seung Hyun Bang; Byoung Jae Kim; Chan Wook Park; Moon Young Kim
Journal:  J Korean Med Sci       Date:  2020-07-06       Impact factor: 2.153

4.  Atherogenic index of plasma is a novel and strong predictor associated with fatty liver: a cross-sectional study in the Chinese Han population.

Authors:  Fangfei Xie; Hong Zhou; Yun Wang
Journal:  Lipids Health Dis       Date:  2019-09-12       Impact factor: 3.876

5.  Prevalence and risk factors of non-alcoholic fatty liver disease in southwest Iran: a population-based case-control study.

Authors:  Elaheh Zarean; Reza Goujani; Ghorbanali Rahimian; Ali Ahamdi
Journal:  Clin Exp Hepatol       Date:  2019-09-05

6.  Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in China.

Authors:  Fangfei Xie; Yuyu Pei; Quan Zhou; Deli Cao; Yun Wang
Journal:  Lipids Health Dis       Date:  2021-10-10       Impact factor: 3.876

7.  A nomogram incorporated lifestyle indicators for predicting nonalcoholic fatty liver disease.

Authors:  Kaili Peng; Shuofan Wang; Linjiao Gao; Huaqiang You
Journal:  Medicine (Baltimore)       Date:  2021-07-02       Impact factor: 1.817

8.  Combination of Hypertension Along with a High Fat and Cholesterol Diet Induces Severe Hepatic Inflammation in Rats via a Signaling Network Comprising NF-κB, MAPK, and Nrf2 Pathways.

Authors:  Yuan Yuan; Hisao Naito; Xiaofang Jia; Kazuya Kitamori; Tamie Nakajima
Journal:  Nutrients       Date:  2017-09-14       Impact factor: 5.717

9.  Clinical Manifestations and Diagnosis of Nonalcoholic Fatty Liver Disease.

Authors:  Mahmoodreza Khoonsari; Mohammadreza Mohammad Hosseini Azar; Ramak Ghavam; Khadijeh Hatami; Mosa Asobar; Ali Gholami; Abdolhalim Rajabi; Fahimeh Safarnezhad Tameshkel; Bahare Amirkalali; Masoudreza Sohrabi
Journal:  Iran J Pathol       Date:  2017-04-01

10.  Changes in Office Blood Pressure Control, Augmentation Index, and Liver Steatosis in Kidney Transplant Patients after Successful Hepatitis C Infection Treatment with Direct Antiviral Agents.

Authors:  Aureliusz Kolonko; Joanna Musialik; Jerzy Chudek; Magdalena Bartmańska; Natalia Słabiak-Błaż; Agata Kujawa-Szewieczek; Piotr Kuczera; Katarzyna Kwiecień-Furmańczuk; Andrzej Więcek
Journal:  J Clin Med       Date:  2020-03-30       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.